In conclusion, as shown in Figure 6, restoration of systemic, renal tissue and renal arterial PPARγ by chronic pioglitazone treatment attenuated cirrhosis-related renal dysfunction and endotoxemia-induced acute on chronic renal dysfunction. Here, PPARG is linked to serum lipopolysaccharide activity.